Home
About Cytheris
Corporate Overview
Executive Management
Board of Directors
Clinical Advisory Board
Academic Partners
History
Science
Portfolio Overview
Interleukin-7
NKT Ligands
Pipeline & Products
Development Pipeline
IL-7 in Oncology
IL-7 in HIV
IL-7 in HCV
NKT Ligands
Intellectual Property
Manufacturing
Clinical Trials
Clinical Trials Overview
IL-7 Oncology Trials
IL-7 HIV Trials
IL-7 HCV Trials
Other IL-7 Trials
Business Development
News Room
Press Releases
Calendar of Events
Investors
Careers
Contact Us
DOWNLOAD CORPORATE
FACT SHEET (PDF)
DOWNLOAD CORPORATE
PRESENTATION (PDF)
Press Releases 2008
June 26, 2008
Cytheris Announces Publication of IL-7 Oncology Data in The Journal of Experimental Medicine
FR
April 23, 2008
Cytheris Announces New Phase I Study of Interleukin-7 As Immunotherapy In Treatment of Bone Marrow or Peripheral Blood Stem Cell Transplant Patients
FR
March 26, 2008
Laureate Announces Second Manufacturing Agreement
with Cytheris
FR
February 13, 2008
Cytheris Announces 48-Week Results of Phase I/II Study Showing Administration of Interleukin-7(IL-7) Significantly Improves CD4 T-Cell Counts in Chronically Infected HIV-1 Patients
FR
Press 2007
Press 2006
Press 2005
Press 2004
Press 2002
Home
About Cytheris
Science
Pipeline & Products
Clinical Trials
Business Development
News Room
Careers
Contact Us
Sitemap
Privacy Policy
Terms of Use
© 2008 Cytheris, Inc. All rights reserved.